CorMedix Inc. (CRMD) NASDAQ

Currency In USD

AD

CorMedix Inc.

Address

389 Interpace Pkwy

Parsippany, NJ 07054

United States of America (the)

Phone

908 517 9500

Sector

Healthcare

Industry

Biotechnology

Employees

191

First IPO Date

May 13, 2010

Key Executives

NameTitlePayYear Born
Joseph TodiscoCEO & Chairman of the Board of Directors1.61M1976
Michael SecklerExecutive Vice President & Chief Commercial Officer561,5711966
Matthew T. DavidEVP & Chief Business Officer634,8551978
Susan BlumExecutive Vice President & Chief Financial Officer634,8551973
Elizabeth HurlburtExecutive VP and Chief Operating & Commercial Officer959,3701979
Kaufman Beth ZelnickEVP, Chief Legal and Compliance Officer & Corporate Secretary981,5921961
Jared L. CrandonExecutive Director of Clinical Portfolio Management0N/A
Donna UcciSenior Vice President & Head of Global Quality0N/A
Beth SteinbrennerSVP & Chief Human Resource Officer0N/A
Peter Sullivan BCOPSenior Vice President of Market Access0N/A
Tushar MukherjeeSenior Vice President & Head of Technical Operations0N/A
AD

Description

CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. This treatment aims to diminish and avert catheter-related infections and blood clots in patients who utilize central venous catheters for medical procedures such as hemodialysis, total parenteral nutrition, and oncology care. Incorporated in 2006, the company initially operated as Picton Holding Company, Inc. until officially adopting the name CorMedix Inc. in January 2007. Its corporate headquarters are located in Berkeley Heights, New Jersey.

AD